Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Bai, Yun, Kan, Shifeng, Zhou, Shixin, Wang, Yuting, Xu, Jun, Cooke, John P, Wen, Jinhua, Deng, Hongkui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004231/
https://www.ncbi.nlm.nih.gov/pubmed/27625791
http://dx.doi.org/10.1038/celldisc.2016.32
_version_ 1782450765969752064
author Bai, Yun
Kan, Shifeng
Zhou, Shixin
Wang, Yuting
Xu, Jun
Cooke, John P
Wen, Jinhua
Deng, Hongkui
author_facet Bai, Yun
Kan, Shifeng
Zhou, Shixin
Wang, Yuting
Xu, Jun
Cooke, John P
Wen, Jinhua
Deng, Hongkui
author_sort Bai, Yun
collection PubMed
description
format Online
Article
Text
id pubmed-5004231
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50042312016-09-13 Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA Bai, Yun Kan, Shifeng Zhou, Shixin Wang, Yuting Xu, Jun Cooke, John P Wen, Jinhua Deng, Hongkui Cell Discov Corrigendum Nature Publishing Group 2016-08-30 /pmc/articles/PMC5004231/ /pubmed/27625791 http://dx.doi.org/10.1038/celldisc.2016.32 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Corrigendum
Bai, Yun
Kan, Shifeng
Zhou, Shixin
Wang, Yuting
Xu, Jun
Cooke, John P
Wen, Jinhua
Deng, Hongkui
Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
title Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
title_full Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
title_fullStr Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
title_full_unstemmed Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
title_short Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA
title_sort enhancement of the in vivo persistence and antitumor efficacy of cd19 chimeric antigen receptor t cells through the delivery of modified tert mrna
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004231/
https://www.ncbi.nlm.nih.gov/pubmed/27625791
http://dx.doi.org/10.1038/celldisc.2016.32
work_keys_str_mv AT baiyun enhancementoftheinvivopersistenceandantitumorefficacyofcd19chimericantigenreceptortcellsthroughthedeliveryofmodifiedtertmrna
AT kanshifeng enhancementoftheinvivopersistenceandantitumorefficacyofcd19chimericantigenreceptortcellsthroughthedeliveryofmodifiedtertmrna
AT zhoushixin enhancementoftheinvivopersistenceandantitumorefficacyofcd19chimericantigenreceptortcellsthroughthedeliveryofmodifiedtertmrna
AT wangyuting enhancementoftheinvivopersistenceandantitumorefficacyofcd19chimericantigenreceptortcellsthroughthedeliveryofmodifiedtertmrna
AT xujun enhancementoftheinvivopersistenceandantitumorefficacyofcd19chimericantigenreceptortcellsthroughthedeliveryofmodifiedtertmrna
AT cookejohnp enhancementoftheinvivopersistenceandantitumorefficacyofcd19chimericantigenreceptortcellsthroughthedeliveryofmodifiedtertmrna
AT wenjinhua enhancementoftheinvivopersistenceandantitumorefficacyofcd19chimericantigenreceptortcellsthroughthedeliveryofmodifiedtertmrna
AT denghongkui enhancementoftheinvivopersistenceandantitumorefficacyofcd19chimericantigenreceptortcellsthroughthedeliveryofmodifiedtertmrna

Ejemplares similares